Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development

Integration with Proscia’s Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs August 18, 2026  Imagene AI, a leader in AI-powered precision oncology, today announced that it has joined the Proscia Ready partner alliance. Imagene AI is collaborating with Proscia® to integrate its advanced H&E tools […]

Imagene AI and Tel Aviv Sourasky University Medical Center (Ichilov) Build Clinical AI Infrastructure to Advance Precision Oncology and Biopharma R&D

The collaboration will enable the development, validation, and application of advanced AI technologies to identify clinically meaningful patient subgroups, support biomarker-driven clinical trials, and create a platform for biopharma partnerships advancing innovation and personalized medicine. July 16, 2026  Imagene AI, a pioneer in multimodal AI for precision oncology, and Tel Aviv Sourasky University Medical Center […]

Imagene AI Announces Collaboration with Daiichi Sankyo to Advance Multimodal Biomarker Discovery in Oncology

Collaboration leverages Imagene’s OI Suite, powered by CanvOI and a large-scale multimodal real-world data lake, alongside Composite Continuous Scoring to strengthen biomarker-driven decisions. April 9, 2026  Imagene AI, a pioneer in multimodal AI for precision oncology, today announced a collaboration with Daiichi Sankyo (TSE: 4568) to advance biomarker discovery and response prediction in oncology drug […]

Imagene AI and Shaare Zedek Medical Center Form Strategic Data-AI Collaboration to Scale Oncology Research and Care

The collaboration combines Shaare Zedek’s real-world data and clinical expertise with Imagene AI’s Oncology Intelligence Suite to advance biomarker discovery and accelerate precision cancer care. October 29, 2025 [NewsWire] Imagene AI, a pioneer in multimodal foundation models for precision oncology, and Shaare Zedek Scientific, the innovation arm of Shaare Zedek Medical Center, today announced a […]

Imagene AI Launches the Oncology Intelligence (OI) Suite Discovery Program at Oracle AI World

OI Suite Discovery Program launches with complimentary access for researchers in biopharma companies and academic centers to accelerate biomarker discovery through an intuitive, no-code interface. CanvOI, running on Oracle Cloud Infrastructure (OCI), is now trained on more than 1.5 million biopsy images across 40+ organs and designed to perform in small early-phase cohorts.   October […]

To submit a case, follow these steps: